Reducing Cardiovascular Events and End-Organ Damage in Patients with Hypertension: New Considerations

被引:3
作者
Harmon, Laura [2 ]
Chilton, Robert J. [1 ]
Spellman, Craig [3 ,4 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Cardiol, San Antonio, TX 78229 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA
[3] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Div Endocrinol, Midland, TX USA
[4] Texas Tech Univ, Hlth Sci Ctr, Ctr Diabet & Metab Disorders, Midland, TX USA
关键词
hypertension; antihypertensives; blood pressure control; cardiovascular risk; RENIN INHIBITOR ALISKIREN; TYPE-2; DIABETES-MELLITUS; LEFT-VENTRICULAR MASS; BLOOD-PRESSURE; CLINICAL-OUTCOMES; ANTIHYPERTENSIVE EFFICACY; SCIENTIFIC STATEMENT; COMBINATION THERAPY; HEART-FAILURE; BETA-BLOCKERS;
D O I
10.3810/pgm.2011.03.2258
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension treatment should focus on achieving blood pressure (BP) of < 140/90 mm Hg in most patients and < 130/80 mm Hg in patients with diabetes. Lifestyle modifications play a central role in therapy and should be the first line of treatment in all patients. However, long-term lifestyle changes are rarely achieved and pharmacotherapy is required. The selection of an optimal regimen for each patient will depend on comorbid conditions. Most patients will require combination therapy with >= 2 antihypertensive agents to control their BP. The most useful combinations employ drugs from different classes with complementary mechanisms of action, producing additive or synergistic BP reduction with minimal adverse events.
引用
收藏
页码:7 / 17
页数:11
相关论文
共 76 条
  • [1] Agodoa L, 2007, J HYPERTENS, V25, P951
  • [2] Standards of Medical Care in Diabetes-2010
    不详
    [J]. DIABETES CARE, 2010, 33 : S11 - S61
  • [3] Andrade SE, 2004, AM J MANAG CARE, V10, P481
  • [4] Antihypertensive T., 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI [10.1001/jama.288.23.2981, DOI 10.1001/JAMA.288.23.2981]
  • [5] The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition
    Atlas, Steven A.
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (08): : S9 - S20
  • [6] Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome
    Azadbakht, L
    Mirmiran, P
    Esmaillzadeh, A
    Azizi, T
    Azizi, F
    [J]. DIABETES CARE, 2005, 28 (12) : 2823 - 2831
  • [7] Renin inhibition
    Azizi, Michel
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2006, 15 (05) : 505 - 510
  • [8] ASH Position Paper: Treatment of Hypertension in Patients With Diabetes-An Update
    Bakris, George L.
    Sowers, James R.
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (09) : 707 - 713
  • [9] Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension - A randomized controlled trial
    Bakris, GL
    Fonseca, V
    Katholi, RE
    McGill, JB
    Messerli, FH
    Phillips, RA
    Raskin, P
    Wright, JT
    Oakes, R
    Lukas, MA
    Anderson, KM
    Bell, DSH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (18): : 2227 - 2236
  • [10] Preserving renal function in adults with hypertension and diabetes: A consensus approach
    Bakris, GL
    Williams, M
    Dworkin, L
    Elliott, WJ
    Epstein, M
    Toto, R
    Tuttle, K
    Douglas, J
    Hsueh, W
    Sowers, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) : 646 - 661